6月12日,浙江省医保局集中公示了一批调整挂网的药品名单,多家企业生产的磷酸奥司他韦胶囊、克林霉素磷酸酯注射液被调整药品价格或者暂停挂网。浙江医保局未披露这批药品的相关价格,仅指出公示名单中部分药品曾因价格遭到投诉,经专家评估、议价后得出了这次结果。该名单基本覆盖了绝大多数奥司他韦的生产企业,博瑞制药、普利药业等被标注为“调整挂网价格”,东阳光长江药业、成都倍特的产品都被指出“不符合要求”,直接...
Source Link6月12日,浙江省医保局集中公示了一批调整挂网的药品名单,多家企业生产的磷酸奥司他韦胶囊、克林霉素磷酸酯注射液被调整药品价格或者暂停挂网。浙江医保局未披露这批药品的相关价格,仅指出公示名单中部分药品曾因价格遭到投诉,经专家评估、议价后得出了这次结果。该名单基本覆盖了绝大多数奥司他韦的生产企业,博瑞制药、普利药业等被标注为“调整挂网价格”,东阳光长江药业、成都倍特的产品都被指出“不符合要求”,直接...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.